Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure
Intensive Care Med
.
2020 Oct;46(10):1924-1926.
doi: 10.1007/s00134-020-06177-1.
Epub 2020 Jul 15.
Authors
Noémie Zucman
1
,
Jimmy Mullaert
2
,
Damien Roux
3
,
Oriol Roca
4
,
Jean-Damien Ricard
5
;
Contributors
Collaborators
Contributors
:
Dan Longrois
,
Didier Dreyfuss
Affiliations
1
Assistance Publique-Hôpitaux de Paris, DMU ESPRIT, Médecine Intensive Réanimation, Medico-Surgical ICU, Louis Mourier Hospital, 92700, Colombes, France.
2
Assistance Publique-Hôpitaux de Paris, Department of Epidemiology, Biostatistics and Clinical Research, Hôpital Bichat, 75018, Paris, France.
3
Université de Paris, IAME, INSERM, UMR 1137, Paris, France.
4
Critical Care Department, Vall D'Hebron University Hospital, Vall D'Hebron Research Institute, 08035, Barcelona, Spain.
5
Assistance Publique-Hôpitaux de Paris, DMU ESPRIT, Médecine Intensive Réanimation, Medico-Surgical ICU, Louis Mourier Hospital, 92700, Colombes, France.
[email protected]
.
PMID:
32671470
PMCID:
PMC7362315
DOI:
10.1007/s00134-020-06177-1
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
Respiratory Insufficiency*
Respiratory Rate*
SARS-CoV-2